1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Aquarius Surgical Technologies Inc.

Aquarius Surgical Technologies Inc.

AQQRF
Aquarius Surgical Technologies Inc.US flagOther OTC
0.00
USD
- -
- -
115,917.00Market Cap
Aquarius Surgical Technologies Inc.
AQQRF
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.04
0.06
0.05
0.03
- -
- -
- -
- -
0.05
0.02
0.04
0.03
0.01
0.01
0.01
- -
- -
Revenue per Share
-0.07
-0.05
-0.05
-0.05
0.03
-0.04
0.03
-0.14
-0.35
-0.08
-0.07
-0.08
-0.04
-0.03
-0.03
-0.04
-0.04
Basic EPS, GAAP
-0.06
-0.04
-0.04
-0.06
-0.04
-0.05
-0.01
-0.05
-0.09
-0.09
-0.05
-0.02
-0.01
- -
-0.01
-0.01
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-3.46
-3.51
-3.56
-3.61
-3.58
-3.62
-3.59
-0.34
-0.44
-0.47
-0.43
-0.51
-0.54
-0.53
-0.5
-0.55
-0.57
Book Value per Share
-0.59
-0.61
-0.66
-0.71
-0.68
-0.73
-0.72
-0.18
0.01
-0.02
-0.03
-0.1
-0.14
-0.15
-0.17
-0.21
-0.23
Tangible Book Value per Share
5
5
5
5
5
5
5
6
18
19
23
23
23
25
28
28
28
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
1
1
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
-149.11
-78.98
-85.24
-147.39
- -
- -
- -
-14,981.42
-196.91
-349.03
-137.12
-135.88
-209.79
-319.89
-238.54
-598.19
-406.51
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
-1
-6
-2
-2
-2
-1
-1
-1
-1
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-159.58
-80.85
-99.38
-156.18
- -
- -
- -
-14,865.28
-641.52
-403.35
-168
-310.3
-262.22
-355.09
-369.14
-1,279.85
-1,550.54
Profit Margin (%)
-3
-3
-4
-4
-4
-4
-4
2
1
- -
- -
- -
-1
-1
-2
-2
-2
Working Capital
- -
- -
- -
- -
- -
- -
- -
2
1
2
2
2
2
3
3
6
6
LT Debt
-3
-3
-4
-4
-4
-4
-4
5
- -
- -
-1
-2
-3
-4
-5
-6
-6
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
-1.08
- -
-0.85
- -
- -
- -
- -
- -
- -
- -
- -
- -
-5.29
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'26
Sep'26
Dec'26
ST Debt
- -
- -
1
LT Borrowings
6
6
6
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
28
28
28
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Jun'26
Sep'26
Dec'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
2
2
Payables & Accruals
1
1
1
ST Debt
- -
- -
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-38.3%
69.29%
25.34%
Free Cash Flow
19.38%
-194.62%
49.18%
Net Income, GAAP
-26.33%
0.57%
54.06%
Sales/Revenue/Turnover
- -
-35.13%
-55.57%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
-0.01
-0.01
- -
-0.03
2025
-0.01
-0.01
-0.01
- -
-0.04
2026
0.03
-0.03
-0.02
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858.HK)
A-SPINE Asia Co., Ltd. (6758.TWO)
Gentian Diagnostics ASA (GENT.OL)
Inspire Medical Systems, Inc. (INSP)
Stryker Corporation (SYK.DE)
Integrum AB (publ) (INTEG-B.ST)
Business
Aquarius Surgical Technologies Inc. (CSE: ASTI, OTC: AQQRF) provides innovative, minimally invasive medical laser systems and consumables principally for urology; through its wholly owned subsidiary Surgical Lasers Inc., it offers integrated laser-based solutions across multiple medical disciplines including gynecology, ophthalmology, thoracic surgery, ear nose and throat (ENT), cardiovascular, and neurosurgery; solutions also encompass clinical education, service, support, maintenance, and cost-effective consumables focused on enhancing patient care, operational efficiencies, and reducing total costs; the company generates revenue from sales and service operations internationally, with emphasis on North America including Canada and the United States. Founded in 1986 and headquartered in Toronto, Canada, Aquarius Surgical Technologies specializes in the development, sale, distribution, marketing, and exploitation of surgical technologies. Recent developments include a debt settlement agreement eliminating $196,000 in accrued debt through the issuance of 3,920,000 common shares to a related party; issuance of 600,000 shares as compensation to non-executive directors and officers; and ongoing sales highlighted by acquisitions of FDA-approved products such as the Pathfinder Laser for benign prostate treatment, alongside strategic efforts to expand market presence through organic growth and partnerships.